Bioness has completed the initial enrolment phase of the FASTEST study to further examine the affect of its Ness L300 wireless neurostimulation technology on individuals with foot drop.

The Ness L300 provides an electrical stimulus to the muscles of the lower leg in order to help lift the foot up while walking.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

More than 170 people have been enrolled on the study, which hopes to demonstrate the superiority of the Ness L300 Foot Drop System over standard ankle-foot orthosis therapy.

Patients will receive either the Ness L300 or AFO rehabilitation therapies. They will be monitored for six months and evaluated based on gait function, stroke-specific quality of life and safety.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
Awarded for Innovation in Remote Hearing Diagnostics , hearX’s Self Test Kit (STK) delivers clinically validated audiometry via smart devices, enabling remote, scalable hearing assessments in homes, clinics and retail. Learn how hearX is redefining hearing care delivery and reducing costs for providers globally.

Discover the Impact